Switching from algorithm-based to universal admission screening for COVID-19 in hospital settings
Donker, T.; Grundmann, H.; Bürkin, F.; Hengel, H.; Bürkle, H.; Hammer, T.; Wenz, F.; Kern, W.
Show abstract
Detection of COVID-19 positive cases on admission to hospitals is crucial to protect patients and staff at the same time. While universal admission screening can prevent more undetected introductions than the algorithm-based screening, which preselects patient based on their symptoms and exposure, it is a more costly strategy as it involves testing a large number of patients. We construct a simple tool to help determine when the benefit of additionally found cases outweighs the cost of the additionally tested patients, based on the numbers of patients to be screened in an acceptable time span to find an additional case when screening all admitted patients.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Pre-test probability for SARS-Cov-2-related Infection Score: the PARIS score 93%
- Threshold analyses on rates of testing, transmission, and contact for COVID-19 control in a university setting 93%
- Reduced turnaround times through multi-sectoral collaboration during the first surge of SARS-CoV-2 in Louisiana, March-April 2020 93%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- A model-based evaluation of the efficacy of COVID-19 social distancing, testing and hospital triage policies 92%
- An agent-based model to simulate the transmission dynamics of bloodborne pathogens within hospitals 92%
- An expert judgment model to predict early stages of the COVID-19 outbreak in the United States 92%
Similar papers in this journal
- A Data-Driven Framework for Identifying Intensive Care Unit Admissions Colonized with Multidrug-Resistant Organisms 94%
- Real-time estimation of R_0 for supporting public-health policies against COVID-19 92%
- AI-Driven Early Detection of Severe Influenza in Jiangsu, China: A Deep Learning Model Validated Through The Design of Multi-Center Clinical Trials and Prospective Real-World Deployment 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.